Ticker Details
LeMaitre Vascular, Inc. LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
IPO Date:	October 19, 2006
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$2.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 1.85%
Avg Daily Range (30 D):	$1.05 | 1.21%
Avg Daily Range (90 D):	$1.05 | 1.22%

Institutional Daily Volume
Avg Daily Volume:	.07M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.11M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	31
Avg Trade Size (Sh.) (90 D):	32

Institutional Trades
Total Institutional Trades:	1,668
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$1.79M
Avg Institutional Trade (90 D):	$2.2M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.66M
Avg Closing Trade (30 D):	$1.9M
Avg Closing Trade (90 D):	$2.36M
Avg Closing Volume:	27.05K

News

Oct 9, 2025 @ 9:53 PM LeMaitre Will Announce Third Quarter 2025 Earnings... Source: Lemaitre Vascular, Inc.

Aug 6, 2025 @ 5:09 AM LeMaitre (LMAT) Q2 Revenue Jumps 15% Source: Jesterai

Jun 10, 2025 @ 2:52 AM Anteris Appoints David Roberts and Gregory Moss to... Source: Anteris Technologies Global Corp.

Dec 16, 2024 @ 12:57 PM LeMaitre Vascular Announces Proposed Convertible S... Source: Globe Newswire

Nov 1, 2024 @ 8:47 PM LeMaitre to Participate at Upcoming Investor Confe... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.77	$.61
Diluted EPS		$.75	$.6
Revenue		$61.05M	$64.23M
Gross Profit		$45.96M	$44.97M
Net Income / Loss		$17.36M	$13.78M
Operating Income / Loss		$20.31M	$16.14M
Cost of Revenue		$15.09M	$19.26M
Net Cash Flow		$-1.63M	$1.18M
PE Ratio